The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

"The committee has been plagued with persistent conflicts of interest and has become little more than a rubber stamp for any ...

The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.

The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Moderna’s coronavirus vaccine is similar to the Pfizer-BioNTech vaccine that was authorized and shipped out to Americans earlier this week. But there are a few key differences.

The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...

Moderna's vaccine candidate was found to be 94.1% effective in preventing COVID-19 in clinical trials, and it doesn't trigger severe side effects in most people.

The transparency around our review of the Moderna COVID-19 vaccine should reassure the public that this vaccine met the FDA’s rigorous standards for quality, safety and efficacy.

Moderna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune response in late-stage study results than two comparable vaccines on the market.

Two COVID-19vaccines are now authorized in the United States. The Moderna vaccine began arriving across the nation Monday, just three days after it was authorized for emergency use by the Food and ...